Monoamine oxidase activity in the term human placenta.

Area of Science:

• Biochemistry
• Obstetrics
• Pharmacology

Background:

• Placental monoamine oxidase (MAO) plays a role in metabolizing vasoactive substances.
• Decreased placental blood flow is a concern in high-risk pregnancies.

Purpose of the Study:

• To measure placental MAO activity in normal and high-risk pregnancies.
• To investigate the effects of certain drugs and metabolites on placental MAO activity.

Main Methods:

• Radioenzymatic assay used to measure MAO activity in placental tissue.
• Comparison of MAO activity between healthy controls and high-risk pregnancies (hypertension, toxemia, diabetes).
• Assessment of drug (hydralazine, magnesium sulfate) and metabolite (butyrate) effects on MAO activity in vitro.

Main Results:

• Placental MAO activity was significantly reduced in high-risk pregnancies compared to controls.
• MAO activity was similar in placentas from spontaneous labor and elective cesarean sections.
• Hydralazine, magnesium sulfate, and butyrate showed varying effects on MAO activity in placental homogenates and explants.

Conclusions:

• Placental MAO activity is lower in term high-risk pregnancies.
• Reduced MAO activity may impair local inactivation of catecholamines and serotonin, potentially decreasing placental blood flow.
• Further studies are needed to confirm a direct relationship between MAO activity and placental blood flow.